Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

Abstract Background and objective To evaluate the cost-effectiveness of new anticoagulants and warfarin in the prevention of stroke in Chinese patients with atrial fibrillation (AF). Methods The Markov model was constructed to compare patients’ quality-adjusted life-years (QALYs) using drug cost, th...

Full description

Bibliographic Details
Main Authors: Hongtao Wei, Can Cui, Xiangli Cui, Yi Liu, Dandan Li
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Health Services Research
Subjects:
Warfarin
Cost‐effectiveness
New oral anticoagulants
Chinese population
Online Access:https://doi.org/10.1186/s12913-021-06084-1

Similar Items

Similar Items